Actively Recruiting
Missed Opportunities for HIV Screening in General Practice
Led by University Hospital, Strasbourg, France · Updated on 2026-01-05
50
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
CONDITIONS
Official Title
Missed Opportunities for HIV Screening in General Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult subject (≥18 years)
- Diagnosed with HIV infection between January 1, 2021, and July 30, 2024
You will not qualify if you...
- Arrived in France in the year preceding or during January 1, 2024 to July 30, 2024
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
B
baptiste Hoellinger, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here